BIOQUELL Cleaning Process Highly Effective against MRSA

A recently published paper in the Journal of Hospital Infection, jointly written by BIOQUELL / King's College London / Guy's and St Thomas' Hospital, has shown that conventional cleaning is insufficient against MRSA, but a patented decontamination process from BIOQUELL can be highly effective in eliminating environmental MRSA.

BIOQUELL plc, is the UK developer of a unique bio-decontamination technology. Despite a number of new initiatives to combat the problem of MRSA, the UK continues to have the second worst rates of MRSA in Europe, and the incidence continues to increase. There is evidence that indicates environmental contamination contributes to infection rates and that these bacteria can survive in the environment for long periods of time - for example, MRSA has been detected as being viable after 12 months.

In 2000, mindful of the increasing global MRSA problem, Professor Gary French (of King’s College London and Guy’;;;s and St Thomas’ Hospital) and BIOQUELL agreed to carry out research at St Thomas’ Hospital into tackling MRSA contamination. The objective of the research was to investigate the level of MRSA in the hospital, focussing initially on likely MRSA problem areas, and a comparison of the effectiveness of cleaning and BIOQUELL’s technology to decontaminate MRSA. The table here shows a summary of the results.

These results show the effectiveness of the Clarus™ range of biodecontamination technology which uses hydrogen peroxide vapour to bio-deactivate micro-organisms such as bacteria, viruses and fungi. At the end of the biodecontamination process, hydrogen peroxide is catalytically converted to water and oxygen – so the technology is "residue-free".

BIOQUELL also has a service side to its business via the provision of a Room Bio-Decontamination Service ("RBDS") and an Equipment Bio-Decontamination Service ("EBDS").

REFERENCE:
May edition of Journal of Hospital Infection (this edition will be available on-line sh ortly) T>